Edap Tms S.A. (NASDAQ:EDAP) Short Interest Up 60.9% in March

Edap Tms S.A. (NASDAQ:EDAP) was the recipient of a significant growth in short interest in March. As of March 15th, there was short interest totalling 112,300 shares, a growth of 60.9% from the February 29th total of 69,800 shares. Based on an average daily trading volume, of 40,900 shares, the short-interest ratio is presently 2.7 days.

Edap Tms Stock Up 3.5 %

Shares of EDAP stock traded up $0.25 on Friday, hitting $7.35. The stock had a trading volume of 58,411 shares, compared to its average volume of 51,834. The business has a 50 day moving average of $6.71 and a 200 day moving average of $6.15. The company has a debt-to-equity ratio of 0.04, a quick ratio of 2.50 and a current ratio of 3.09. Edap Tms has a 12-month low of $3.60 and a 12-month high of $12.23.

Analyst Ratings Changes

Separately, StockNews.com downgraded shares of Edap Tms from a “hold” rating to a “sell” rating in a report on Tuesday, February 13th.

Institutional Trading of Edap Tms

Institutional investors and hedge funds have recently made changes to their positions in the company. State of Tennessee Treasury Department purchased a new stake in shares of Edap Tms in the fourth quarter valued at about $38,000. New York State Common Retirement Fund increased its holdings in Edap Tms by 391.4% during the first quarter. New York State Common Retirement Fund now owns 4,629 shares of the medical equipment provider’s stock worth $51,000 after buying an additional 3,687 shares during the last quarter. Milestone Investment Advisors LLC bought a new position in Edap Tms during the third quarter worth about $39,000. Russell Investments Group Ltd. boosted its position in Edap Tms by 202.2% during the first quarter. Russell Investments Group Ltd. now owns 5,784 shares of the medical equipment provider’s stock worth $63,000 after purchasing an additional 3,870 shares during the period. Finally, BNP Paribas Arbitrage SNC bought a new position in Edap Tms during the third quarter worth about $54,000. Hedge funds and other institutional investors own 62.74% of the company’s stock.

Edap Tms Company Profile

EDAP TMS SA, together with its subsidiaries, develops, produces, markets, distributes, and maintains a portfolio of minimally invasive medical devices for the treatment of urological diseases in Asia, France, the United States, and internationally. It operates in three segments: High Intensity Focused Ultrasound (HIFU), Extracorporeal ShockWave Lithotripsy (ESWL), and Distribution Services (DIST).